SAN

Sanofi News

Kaufen
Verkaufen
Best deals to access real time data!
Euronext
Monthly Subscription
for only
11,81 €
Euronext Level 2
Monthly Subscription
for only
22,17 €
GOLD TRADER
Monthly Subscription
for only
121,88 €
VAT not included
Name Symbol Markt Aktientyp
Sanofi SAN Euronext Ordinary Share
  Änderung Änderung % Aktuell Zeit
-0,29 -0,34% 83,84 17:40:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
84,05 83,31 84,20 83,84 84,13
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
13.10.202109:00GLOBEPrésentation à l’ECTRIMS 2021 de nouvelles données à long..
01.10.202120:28GLOBESanofi: Informations relatives au nombre de droits de vote..
30.9.202114:30GLOBEPrésentation à l’EADV de nouvelles données de dernière..
28.9.202113:50DJNRegeneron Gets FDA Priority Review of Libtayo in Advanced..
28.9.202111:12DJNSanofi to Halt MRNA Covid-19 Vaccine Development Despite..
28.9.202110:28DJNSanofi to Halt MRNA Covid-19 Vaccine Development
28.9.202108:48DJNSanofi Reports Encouraging Early Results In Covid-19 mRNA..
28.9.202108:00GLOBESanofi annonce des résultats intermédiaires positifs de..
24.9.202107:30GLOBESanofi: Availability of the Q3 2021 Memorandum for modelling..
21.9.202107:00GLOBENew Dupixent® (dupilumab) data in patients as young as 6..
19.9.202117:30GLOBEDes données de dernière minute présentées au Congrès de..
14.9.202115:26GLOBESanofi completes acquisition of Translate Bio, accelerating..
09.9.202118:56DJNEuropean Medicines Agency Approves Additional Manufacturing..
09.9.202107:45DJNSanofi's Phase 3 Study of Rilzabrutinib Didn't Meet Primary,..
09.9.202107:00GLOBESanofi fait le point sur l’étude de phase III consacrée au..
09.9.202101:38DJNADRs End Lower; Nio, Sanofi Among Companies Actively Trading
08.9.202117:23DJNKadmon Shares Rise 72% After Sanofi Bid of $9.50 a Share
08.9.202114:08GLOBESanofi va acquérir Kadmon pour renforcer la croissance de..
08.9.202112:44DJNKadmon Holdings Shares Jump 77% Premarket After Sanofi..
08.9.202107:51DJNSanofi to Acquire U.S. Biopharmaceutical Company Kadmon
08.9.202107:00GLOBESanofi va acquérir Kadmon pour renforcer la croissance de..
02.9.202116:04DJNVC Daily: Laronde Fundraising Haul Reflects Search for Next..
30.8.202113:58DJNPfizer Study of Abrocitinib Vs Dupixent Meets Main Endpoints
30.8.202113:07DJNRegeneron, Sanofi: Dupixent Hits Endpoints in Atopic..
30.8.202107:00GLOBEDupixent® (dupilumab) pivotal trial meets all primary and..
25.8.202118:31GLOBESanofi: Information concerning the total number of voting..
06.8.202117:43DJNFDA Approves Sanofi Unit's Nexviazyme for Pompe Disease
06.8.202117:42GLOBEFDA approves Nexviazyme® (avalglucosidase alfa-ngpt), an..
05.8.202113:57DJNRegeneron, Sanofi: Libtayo Phase 3 Study Meets Primary..
05.8.202112:00GLOBEPhase 3 trial of Libtayo® (cemiplimab) combined with..
03.8.202112:46DJNTranslate Bio Shares Surge on Takeover by Sanofi
03.8.202107:57DJNSanofi to Buy Translate Bio to Accelerate mRNA-Technology..
03.8.202107:00GLOBESanofi to acquire Translate Bio; advances deployment of mRNA..
29.7.202118:24GLOBEMise en ligne du rapport financier semestriel 2021 de Sanofi
29.7.202113:15DJNRegeneron, Sanofi: Dupixent Hits Endpoints in Chronic..
29.7.202108:17DJNSanofi Names EUROAPI Supervisory Board Chair, Appoints..
29.7.202107:51DJNSanofi Lifts 2021 Guidance After 2Q Sales Grew
29.7.202107:31GLOBESanofi nomme deux nouveaux dirigeants au Comité Exécutif et..
29.7.202107:30GLOBEAccélération des ventes - Perspectives 2021 revues à la..
29.7.202107:00GLOBEDupixent®(dupilumab) améliore significativement les..
22.7.202118:02GLOBESanofi: Information concerning the total number of voting..
20.7.202117:39DJNEU Drug Agency Begins Rolling Review of Sanofi Covid-19..
13.7.202107:30GLOBESanofi announces Paris 2024 Premium partnership for the..
30.6.202118:00GLOBESanofi: Information concerning the total number of voting..
29.6.202110:00GLOBESanofi launches dedicated vaccines mRNA Center of Excellence
28.6.202108:47DJNSanofi Divests 16 Brands From European Consumer Healthcare..
28.6.202108:00GLOBEPremiers résultats positifs pour le nirsevimab contre le VRS..
28.6.202107:00GLOBEDupixent® (dupilumab) SmPC updated with long-term data..
25.6.202107:30GLOBESanofi : Mise en ligne du document «Q2 2021 Memorandum for..
25.6.202107:15GLOBESanofi: Libtayo® (cemiplimab) approved by the European..
Mehr News über diese Aktie »
Kürzlich von Ihnen besucht
EU
SAN
Sanofi
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20211017 11:39:21